Atopic dermatitis (AD) is a chronic, inflammatory skin condition characterized by severe pruritus and recurrent flare-ups, significantly impacting patients’ quality of life. Current treatments, such as corticosteroids and immunomodulators, often provide symptomatic relief but can lead to adverse effects with prolonged use. Seaweed, a sustainable and nutrient-dense resource, has emerged as a promising alternative due to its rich bioactive compounds—polysaccharides, phlorotannins, polyphenols, and chlorophyll—that offer anti-inflammatory, antioxidant, and immunomodulatory properties. This review explores the therapeutic potential of brown, red, and green algae in alleviating AD symptoms, highlighting the effects of specific species, including Undaria pinnatifida, Laminaria japonica, Chlorella vulgaris, and Sargassum horneri. These seaweeds modulate immune responses, reduce epidermal thickness, and restore skin barrier function, presenting a novel, safe, and effective approach to AD management. Further clinical studies are needed to confirm their efficacy and establish dosing strategies, paving the way for seaweed-derived therapies as natural alternatives in AD treatment.

Melanogenesis, essential for skin photoprotection and pigmentation, can lead to disorders like melasma and hyperpigmentation, which are challenging to treat and affect quality of life. Docosatrienoic acid (DTA), a polyunsaturated omega-3 fatty acid, has been identified as a potential regulator of skin aging. This study investigates DTA’s effects on melanogenesis and its underlying molecular mechanisms using in silico and in vitro analyses. SwissSimilarity analysis revealed that DTA shares close structural similarities with known anti-melanogenic lipids, suggesting it may inhibit melanogenesis in similar manners. Our results demonstrated that DTA reduces melanin content and intracellular tyrosinase activity in B16F10 cells, significantly downregulating the mRNA expression of tyrosinase, TRP-1, and TRP-2 by inhibiting MITF translocation to the nucleus. While DTA exhibited mild inhibitory effects on mushroom tyrosinase activity and antioxidant properties at higher concentrations, direct inhibition of tyrosinase is likely not the primary mechanism, as the observed anti-melanogenic effects occurred at much lower concentrations compared to those required for direct tyrosinase inhibition. Together, DTA-mediated modulation of MITF and tyrosinase mRNA expression offers a novel approach to treating hyperpigmentation. DTA’s potential extends into the cosmetic industry, enhancing product stability, functionality, and aesthetics. Further research is needed to explore DTA’s broader applications in skincare and cosmetic formulations.

Melanogenesis, the biological process responsible for melanin synthesis, plays a crucial role in determining skin and hair color, photoprotection, and serving as a biomarker in various diseases. While various factors regulate melanogenesis, the role of fatty acids in this process remains underexplored. This study investigated the anti-melanogenic properties of 10(E)-pentadecenoic acid (10E-PDA) through both in silico and in vitro analyses. SwissSimilarity was utilized to predict the functional properties of 10E-PDA by comparing it with structurally similar lipids known to exhibit anti-melanogenic effects. Subsequent in vitro experiments demonstrated that 10E-PDA significantly reduced melanin production and intracellular tyrosinase activity in α-MSH (melanocyte-stimulating hormone)-stimulated B16F10 melanoma cells without exhibiting significant cytotoxicity at concentrations up to 15 μM. Further mechanistic studies revealed that 10E-PDA inhibited the nuclear translocation of microphthalmia-associated transcription factor (MITF), consistent with the decrease observed in p-MITF protein levels. It also decreased the mRNA levels of tyrosinase-related proteins (TRP-1, TRP-2) and tyrosinase, while reducing the protein levels of TRP-1 and tyrosinase, but not TRP-2. These findings suggest that 10E-PDA exerts its anti-melanogenic effects by modulating the MITF/tyrosinase axis, presenting potential therapeutic implications for skin pigmentation disorders.

Fisheries and Aquatic Sciences

Sargassum serratifolium (S. serratifolium), listed in the Food Code, is known for its antioxidant and anti-inflammatory properties and is used in cosmetic applications. However, due to limited industrial utilization and overaccumulation in marine environments, Sargassum has been designated as a marine pollutant by the UN Environment Agency. To improve resource efficiency and reduce environmental burden, this study developed a dual-extraction strategy to isolate extracellular vesicles (EVs) and extract ethanol-soluble substances from the same S. serratifolium biomass. The extracellular vesicles derived from S. serratifolium (SEVs) were isolated and characterized based on their particle size, morphology, concentration, and cargo molecules, including mRNA and proteins. Their antioxidant and anti-inflammatory activities were evaluated using cellular assays, while their effects on melanogenesis and melanosome transport were assessed in B16F10 melanoma cells. Transcriptomic analysis by RNA sequencing was further performed to investigate the molecular pathways involved in SEV-mediated regulation of melanosome transport. SEVs isolation did not affect the yield or biological activity of the S. serratifolium ethanol-soluble fraction. Based on our previous finding that the ethanol extract of S. serratifolium (ESS) suppresses melanin synthesis, the present study focused on investigating the effects and mechanisms of SEVs on melanogenesis and melanosome transport. SEVs were nanoscale vesicles containing mRNA and proteins and showed antioxidant and anti-inflammatory effects in cellular assays. Although SEVs did not reduce melanin production in B16F10 cells, they significantly inhibited melanosome transport. RNA sequencing suggested that SEVs regulated melanosome transport through pathways related to the extracellular matrix, actin filament organization, and calcium ion homeostasis. These findings suggest that SEVs exert anti-melanogenic effects by targeting melanosome transport, providing a complementary mechanism to the previously reported inhibition of melanin synthesis by ESS. These findings demonstrate a sustainable strategy for producing functional EVs and bioactive extracts from a single S. serratifolium biomass source and support their potential use in cosmetic or therapeutic applications targeting hyperpigmentation.